AI Article Synopsis

  • Histidine-tryptophan-ketoglutarate cardioplegia can cause acute hyponatremia in patients undergoing complex cardiac surgery due to its low sodium concentration (15 mmol/L), despite having a slightly hypertonic osmolality.
  • A study monitored 25 cardiac surgery patients, measuring sodium levels, osmolality, and pH at various time points after anesthesia and cardioplegia administration, revealing significant drops in sodium levels shortly after the procedure.
  • The findings suggest that while acute hyponatremia occurs, it typically resolves on its own within 18 hours, meaning additional treatment with hypertonic saline is usually unnecessary.

Article Abstract

Introduction: Histidine-tryptophan-ketoglutarate cardioplegia is used for prolonged myocardial protection in complex cardiac surgery. Administration leads to acute hyponatremia in a majority of patients, because of its low sodium concentration (15 mmol/L). However, histidine-tryptophan-ketoglutarate solution's osmolality is slightly hypertonic (310 mOsm/kg). Hypothesized was that acute hyponatremia will be induced, which does not need to be corrected with hypertonic saline.

Methods: Cardiac surgery patients who received histidine-tryptophan-ketoglutarate cardioplegia were included in this prospective single center study. Serial blood samples were taken from each patient at five different time points: after induction of anesthesia (T1) and 10 minutes (T2), 6 hours (T3), 12 hours (T4), and 18 hours (T5) after administration of histidine-tryptophan-ketoglutarate cardioplegia, respectively. Blood samples were analyzed for sodium concentration, osmolality, and acid-base balance.

Results: Twenty-five patients were included. Median blood sodium levels decreased from 140 [138-141] at T1 to 128 [125-130] mmol/L at T2 (p < 0.001). At T3, T4, and T5, median blood sodium concentrations were 136 [134-138], 139 [137-140], and 140 [137-142] mmol/L, respectively. Median osmolality was 289 [286-293] at T1 and increased to 296 [291-299] mOsm/kg (p < 0.001) at T2. At T3, T4, and T5, osmolality was 298 [292-302], 298 [294-304], and 300 [297-306] mOsm/kg, respectively. Median pH decreased from 7.38 [7.36-7.40] at T1 to 7.30 [7.27-7.32] at T2 (p < 0.001).

Conclusion: Administration of histidine-tryptophan-ketoglutarate cardioplegia during cardiac surgery leads to acute moderate to severe hyponatremia, which resolves spontaneously in the first 18 hours perioperatively. Correction with hypertonic saline is not necessary.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659120946952DOI Listing

Publication Analysis

Top Keywords

histidine-tryptophan-ketoglutarate cardioplegia
16
cardiac surgery
8
acute hyponatremia
8
sodium concentration
8
blood samples
8
histidine-tryptophan-ketoglutarate
5
acute isotonic
4
isotonic hyponatremia
4
hyponatremia single
4
single dose
4

Similar Publications

Objective: Myocardial protection is important for a successful procedure cardiac surgery, and the key element of myocardial protection is cardioplegia. We compared Del Nido cardioplegia (DN) and Bretschneider histidine-tryptophan-ketoglutarate cardioplegia (HTK) regarding cardioprotective effects in a porcine model of prolonged ischaemia.

Methods: Landrace pigs weighing 50-60 kg were randomized to receive either DN ( = 9) or HTK ( = 9).

View Article and Find Full Text PDF

: The optimal choice of cardioplegia solution in minimally invasive cardiac surgeries (MICS) remains debated, as prolonged myocardial protection is essential to avoid interruptions to the surgical flow, which can prolong aortic cross-clamp time and cardiopulmonary bypass time, especially in the constrained surgical field. We conducted a network meta-analysis to evaluate the safety and efficacy of the del Nido (DN), histidine-tryptophan-ketoglutarate (HTK), blood cardioplegia (BC), and St. Thomas' (STH) solutions in MICS.

View Article and Find Full Text PDF

Introduction:  Cardioplegia, a therapy designed to induce reversible cardiac arrest, revolutionized cardiovascular surgery. Among the various pharmacological approaches is the histidine-tryptophan-ketoglutarate (HTK) solution. Despite numerous studies, no meta-analysis has investigated the efficacy of the HTK solution in the pediatric population.

View Article and Find Full Text PDF

Histidine-trytophan-ketoglutarate cardioplegia reduces inflammatory response and serum levels of myocardial enzymes in newly developed right-thoracotomy rat model.

Sci Rep

October 2024

Department of Anesthesiology, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, No. 123, Tianfei Lane, Mochou Road, Nanjing, 210004, Jiangsu, China.

Article Synopsis
  • The research aimed to create a practical and cost-effective rat model for cardiopulmonary bypass (CPB) that simulates clinical cardiac surgery, focusing on cardiac arrest and resuscitation.
  • Thirty rats were divided into three groups receiving different types of cardioplegia: histidine-tryptophan-ketoglutarate (HTK), blood cardioplegia (BC), and del Nido (DN), with the CPB procedure lasting one hour followed by observation.
  • Results showed that HTK cardioplegia led to lower histopathological scores and reduced inflammatory response compared to BC and DN groups, suggesting it may protect the heart more effectively during CPB.
View Article and Find Full Text PDF

Background: Histidine-tryptophan-ketoglutarate (HTK) cardioplegia induces cardiac arrest through membrane hyperpolarization. Aortic valve pathology leads to pathophysiological changes in left ventricular vascularization that may prevent adequate cardioplegic distribution. The objective of the study was to ascertain whether the use of Bretschneider cardioplegia in aortic valve surgery yields different outcomes for male and female patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!